GlaxoSmithKline plc’s US$13bn acquisition of 36.5% stake in its consumer health joint venture with Novartis AG

Freshfields Bruckhaus Deringer has advised Novartis AG on the sale of its 36.5% stake in its consumer health joint venture with GlaxoSmithKline plc for US$13bn. The…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now